Page 678 - Hematology_ Basic Principles and Practice ( PDFDrive )

570.e10 Part V Red Blood Cells

454. Liebhaber SA, Kan YW: alpha-Thalassemia caused by an unstable 479. Li CK, Chan H, Chiu W, et al: Survival of an infant with homozygous
alpha-globin mutant. J Clin Invest 71:461, 1983. alpha thalassemia [abstract]. Pediatr Res 27:266a, 1990.
455. Atkinson SH, Uyoga SM, Nyatichi E, et al: Epistasis between the 480. Lam TK, Chan V, Fok TF, et al: Long-term survival of a baby with
haptoglobin common variant and α+thalassemia influences risk homozygous alpha-thalassemia-1. Acta Haematol 88:198, 1992.
of severe malaria in Kenyan children. Blood 123(13):2008–2016, 481. Singer ST, Styles L, Bojanowski J, et al: Changing outcome of homo-
2014. zygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol
456. Dozy AM, Kan YW, Embury SH, et al: alpha-Globin gene organisa- 22:539, 2000.
tion in blacks precludes the severe form of alpha-thalassaemia. Nature 482. Carr S, Rubin L, Dixon D, et al: Intrauterine therapy for homozygous
280:605, 1979. alpha-thalassemia. Obstet Gynecol 85:876, 1995.
457. Schwartz E, Atwater J: -thalassemia in the American Negro. J Clin Invest 483. Naqvi J, Morrow W, Nisbet-Brown E, et al: Normal development of an
51:412, 1972. infant with homozygous alpha thalassemia [abstract]. Blood 90:132a,
458. Wickramasinghe SN, Hughes M, Fucharoen S, et al: The fate of excess 1997.
beta-globin chains within erythropoietic cells in alpha-thalassaemia 2 484. Chik KW, Shing MM, Li CK, et al: Treatment of hemoglobin Bart’s
trait, alpha-thalassaemia 1 trait, haemoglobin H disease and haemoglo- hydrops with bone marrow transplantation. J Pediatr 132:1039,
bin Q-H disease: an electron microscope study. Br J Haematol 56:473, 1998.
1984. 485. Gibbons RJ, Picketts DJ, Villard L, et al: Mutations in a putative
459. Bowden DK, Hill AV, Higgs DR, et al: Different hematologic pheno- global transcriptional regulator cause X-linked mental retardation with
types are associated with the leftward (-alpha 4.2) and rightward (-alpha alpha-thalassemia (ATR-X syndrome). Cell 80:837, 1995.
3.7) alpha+-thalassemia deletions. J Clin Invest 79:39, 1987. 486. Steensma DP, Higgs DR, Fisher CA, et al: Acquired somatic ATRX
460. Liebhaber SA, Kan YW: Differentiation of the mRNA transcripts mutations in myelodysplastic syndrome associated with alpha thalas-
originating from the alpha 1- and alpha 2-globin loci in normals and semia (ATMDS) convey a more severe hematologic phenotype than
alpha-thalassemics. J Clin Invest 68:439, 1981. germline ATRX mutations. Blood 103:2019, 2004.
461. Orkin SH, Goff SC: The duplicated human alpha-globin genes: their 487. Higgs DR: Gene regulation in hematopoiesis: new lessons from thalas-
relative expression as measured by RNA analysis. Cell 24:345, 1981. semia. Hematology Am Soc Hematol Educ Program 1, 2004.
462. Weatherall DJ: The genetics of the thalassaemias. Br Med Bull 25:24, 488. Steensma DP, Gibbons RJ, Higgs DR: Acquired alpha-thalassemia
1969. in association with myelodysplastic syndrome and other hematologic
463. Liebhaber SA, Cash FE, Cornfield DB: Evidence for posttranslational malignancies. Blood 105:443, 2005.
control of Hb C synthesis in an individual with Hb C trait and alpha- 489. Anagnou NP, Ley TJ, Chesbro B, et al: Acquired alpha-thalassemia
thalassemia. Blood 71:502, 1988. in preleukemia is due to decreased expression of all four alpha-globin
464. Koler RD, Rigas DA: Genetics of haemoglobin H. Ann Hum Genet genes. Proc Natl Acad Sci USA 80:6051, 1983.
25:95, 1961. 490. Gibbons RJ, Pellagatti A, Garrick D, et al: Identification of acquired
465. Chui DH, Fucharoen S, Chan V: Hemoglobin H disease: not neces- somatic mutations in the gene encoding chromatin-remodeling factor
sarily a benign disorder. Blood 101:791, 2003. ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS).
466. Lorey F, Charoenkwan P, Witkowska HE, et al: Hb H hydrops foetalis Nat Genet 34:446, 2003.
syndrome: a case report and review of literature. Br J Haematol 115:72, 491. Humphries RK, Ley T, Turner P, et al: Differences in human alpha-,
2001. beta- and delta-globin gene expression in monkey kidney cells. Cell
467. Sheeran C, Weekes K, Shaw J, et al: Complications of HbH disease in 30:173, 1982.
adulthood. Br J Haematol 167(1):136–139, 2014. 492. Ojwang PJ, Nakatsuji T, Gardiner MB, et al: Gene deletion as the
468. O’Brien RT: The effect of iron deficiency on the expression of hemo- molecular basis for the Kenya-G gamma-HPFH condition. Hemoglobin
globin H. Blood 41:853, 1973. 7:115, 1983.
469. Weatherall DJ, Higgs DR, Clegg JB, et al: The significance of hae- 493. Fairbanks VF, Oliveros R, Brandabur JH, et al: Homozygous hemo-
moglobin H in patients with mental retardation or myeloproliferative globin E mimics beta-thalassemia minor without anemia or hemolysis:
disease. Br J Haematol 52:351, 1982. hematologic, functional, and biosynthetic studies of first North Ameri-
470. Gibbons RJ, Brueton L, Buckle VJ, et al: Clinical and hematologic can cases. Am J Hematol 8:109, 1980.
aspects of the X-linked alpha-thalassemia/mental retardation syndrome 494. Fucharoen S, Winichagoon P: Clinical and hematologic aspects of
(ATR-X). Am J Med Genet 55:288, 1995. hemoglobin E beta-thalassemia. Curr Opin Hematol 7:106, 2000.
471. Weatherall DJ, Clegg JB, Boon WH: The haemoglobin constitution 495. Orkin SH, Kazazian HH, Jr, Antonarakis SE: Abnormal RNA process-
of infants with the haemoglobin Bart’s hydrops foetalis syndrome. Br J ing due to the exon mutation of beta E-globin gene. Nature 300:768,
Haematol 18:357, 1970. 1982.
472. Dozy AM, Forman EN, Abuelo DN, et al: Prenatal diagnosis of 496. Milner PF, Clegg JB, Weatherall DJ: Haemoglobin-H disease due to
homozygous alpha-thalassemia. JAMA 241:1610, 1979. a unique haemoglobin variant with an elongated alpha-chain. Lancet
473. Chan V, Yip B, Lam YH, et al: Quantitative polymerase chain reaction 1:729, 1971.
for the rapid prenatal diagnosis of homozygous alpha-thalassaemia (Hb 497. Kan YW, Todd D, Dozy AM: Haemoglobin Constant Spring synthesis
Barts hydrops fetalis). Br J Haematol 115:341, 2001. in red cell precursors. Br J Haematol 28:103, 1974.
474. Bowden DK, Vickers MA, Higgs DR: A PCR-based strategy to detect 498. Weatherall DJ, Clegg JB: The alpha-chain–termination mutants and
the common severe determinants of alpha thalassaemia. Br J Haematol their relation to the alpha-thalassaemias. Philos Trans R Soc Lond B Biol
81:104, 1992. Sci 271:411, 1975.
475. Chong SS, Boehm CD, Higgs DR, et al: Single-tube multiplex-PCR 499. Adams JG, 3rd, Boxer LA, Baehner RL, et al: Hemoglobin Indianapolis
screen for common deletional determinants of alpha-thalassemia. Blood (beta 112[G14] arginine). An unstable beta-chain variant producing the
95:360, 2000. phenotype of severe beta-thalassemia. J Clin Invest 63:931, 1979.
476. Liu YT, Old JM, Miles K, et al: Rapid detection of alpha-thalassaemia 500. Coleman MB, Steinberg MH, Adams JG, 3rd: Hemoglobin
deletions and alpha-globin gene triplication by multiplex polymerase Terre Haute arginine beta 106. A posthumous correction to the
chain reactions. Br J Haematol 108:295, 2000. original structure of hemoglobin Indianapolis. J Biol Chem 266:5798,
477. Beaudry MA, Ferguson DJ, Pearse K, et al: Survival of a hydropic infant 1991.
with homozygous alpha-thalassemia-1. J Pediatr 108:713, 1986. 501. Thein SL: Structural variants with a beta thalassemia phenotype.
478. Bianchi DW, Beyer EC, Stark AR, et al: Normal long-term survival In Steinberg MH, Forget BG, Higgs DR, et al, editors: Disorders of
with alpha-thalassemia. J Pediatr 108:716, 1986. hemoglobin, New York, 2001, Cambridge University Press, p 342.